Alpine Immune Sciences: ALPN-202 May Be Dead, But The Company Isn't

Oct. 27, 2022 10:33 AM ETAlpine Immune Sciences, Inc. (ALPN)1 Comment
True Orion profile picture
True Orion


  • The recent termination of ALPN-202 trials due to another patient's death caused the share price to plummet.
  • While this was anticipated, I believe that the market has overreacted due to several reasons.
  • The company has enough cash runway to guide them to 2025.
  • ALPN-101 has the potential to be a game-changer in the company's books, while also the multi-use profile of ALPN-303 could also contribute significantly.
  • Together with the ongoing deal with Abbvie, and with 28% upside potential from the ALPN-101 trials alone, the company still represents a nice investment opportunity.

Futuristic 3d cubes background with DNA sequencing ACGT and double helix. Nucleic acid sequence. Genetic research. 3d illustration.


Today I'm taking another look at Alpine Immune Sciences (NASDAQ:ALPN), following my last article about the company, published more than one year ago. Why now? Because news came out a few days ago about another patient who

This article was written by

True Orion profile picture
True Orion is comprised of two notions. Orion, the ancient mythical hunter, and truth. The neverending pursuit for truth. This is my motto. I believe that knowledge is key to achieving oversized returns in a financial as well as in a personal level. As a private investor, with a real estate investment educational background and with more than 15 years of investing experience in the real estate and stock market, I can tell you that. Here in SA, I provide my readers with articles regarding specific stocks, or market analysis. My main focus is in REITs, shipping and value/growth smallcap stocks. Megacaps (usually) leave me tremendously indifferent. The purpose of my articles is to express my ideas and get them tested by reality, while at the same time gain additional knowledge throughout the process. As I said above, the notion of the neverending pursuit of truth is hidden behind True Orion. If you like my content, don't forget to follow me, like, share and comment. As a contributor affiliated with SA, signing up for the SA's premium annual subscription plan by clicking here, you are supporting my efforts even more.

Disclosure: I/we have a beneficial long position in the shares of ALPN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Additional disclosure: This article was written for information purposes only. You should not, in any case, take the contents of this article to be an urge to buy, hold or sell securities. Always perform your own research before investing in the stock market.

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.